Growth Metrics

Novartis Ag (NVS) Shares Outstanding (2018 - 2025)

Novartis Ag recorded quarterly Shares Outstanding of $1.9 billion in Q4 2025, down 3.39% quarter-over-quarter from $2.0 billion in Q4 2024, and down 3.39% year-over-year from $2.0 billion in Q4 2024.

Novartis Ag's Shares Outstanding history runs 8 years deep, the most recent figure standing at $1.9 billion for Q4 2025.

  • In Q4 2025, Shares Outstanding fell 3.39% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $1.9 billion (down 3.39% YoY), while the FY2025 annual figure was $1.9 billion, down 3.39% from the prior year.
  • Shares Outstanding came in at $1.9 billion for Q4 2025 at Novartis Ag, down from $2.0 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.2 billion in Q4 2021 to a low of $1.9 billion in Q4 2025.
  • A 5-year average of $2.1 billion and a median of $2.0 billion in 2023 frame the typical range for Shares Outstanding.
  • Across the five-year window, Shares Outstanding retreated 0.97% in 2021 and declined 5.16% in 2022, its largest moves.
  • Novartis Ag's Shares Outstanding stood at $2.2 billion in 2021, then fell by 5.16% to $2.1 billion in 2022, then slipped by 3.57% to $2.0 billion in 2023, then declined by 3.37% to $2.0 billion in 2024, then fell by 3.39% to $1.9 billion in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods registered $1.9 billion, $2.0 billion, and $2.0 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 943.50 Mn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 3.12 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 1.84 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 3.58 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 539.70 Mn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 1.24 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 9.64 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 2.92 Bn
10 Gsk 88.34 Bn 83.66 Bn - 5.74 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2022 2.12 Bn
Dec 31, 2022 2.12 Bn
Dec 31, 2022 2.12 Bn
Dec 31, 2022 2.12 Bn
Dec 31, 2022 2.12 Bn
Dec 31, 2022 2.12 Bn
Dec 31, 2022 2.12 Bn
Dec 31, 2022 2.12 Bn
Dec 31, 2021 2.23 Bn
Dec 31, 2021 2.23 Bn
Dec 31, 2021 2.23 Bn
Dec 31, 2021 2.23 Bn
Dec 31, 2021 2.23 Bn
Dec 31, 2021 2.23 Bn
Dec 31, 2021 2.23 Bn
Dec 31, 2021 2.23 Bn
Dec 31, 2020 2.26 Bn
Dec 31, 2020 2.26 Bn
Dec 31, 2020 2.26 Bn
Dec 31, 2020 2.26 Bn
Dec 31, 2020 2.26 Bn
Dec 31, 2020 2.26 Bn
Dec 31, 2020 2.26 Bn
Dec 31, 2020 2.26 Bn
Dec 31, 2019 2.27 Bn
Dec 31, 2019 2.27 Bn
Dec 31, 2019 2.27 Bn
Dec 31, 2019 2.27 Bn
Dec 31, 2019 2.27 Bn
Dec 31, 2019 2.27 Bn
Dec 31, 2019 2.27 Bn
Dec 31, 2019 2.27 Bn
Dec 31, 2018 2.31 Bn
Dec 31, 2018 2.31 Bn
Dec 31, 2018 2.31 Bn
Dec 31, 2018 2.31 Bn
Dec 31, 2018 2.31 Bn
Dec 31, 2018 2.31 Bn
Dec 31, 2018 2.31 Bn
Dec 31, 2018 2.31 Bn